Clinical trials launched for treating most aggressive brain tumor with personalized cell vaccines

Researchers have launched a series of clinical trials in order to assess the efficacy of an immunotherapy treatment. This approach involves the application of personalized vaccines -- produced from healthy and tumor cells from the patient him or herself -- and designed to combat glioblastomas, one of the most aggressive and frequent malignant tumors.

Read the whole article on Science Daily

More from Science Daily